Armata Pharmaceuticals Inc (ARMP)
2.10
+0.01
(+0.48%)
USD |
NYAM |
Nov 21, 16:00
2.10
0.00 (0.00%)
After-Hours: 20:00
Armata Pharmaceuticals Enterprise Value: 166.25M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 166.25M |
| November 20, 2024 | 165.88M |
| November 19, 2024 | 161.90M |
| November 18, 2024 | 171.31M |
| November 15, 2024 | 177.46M |
| November 14, 2024 | 187.23M |
| November 13, 2024 | 188.68M |
| November 12, 2024 | 189.77M |
| November 11, 2024 | 171.67M |
| November 08, 2024 | 174.39M |
| November 07, 2024 | 171.31M |
| November 06, 2024 | 170.59M |
| November 05, 2024 | 172.76M |
| November 04, 2024 | 175.29M |
| November 01, 2024 | 175.65M |
| October 31, 2024 | 173.84M |
| October 30, 2024 | 173.48M |
| October 29, 2024 | 173.71M |
| October 28, 2024 | 174.30M |
| October 25, 2024 | 176.74M |
| October 24, 2024 | 176.74M |
| October 23, 2024 | 173.49M |
| October 22, 2024 | 177.10M |
| October 21, 2024 | 175.63M |
| October 18, 2024 | 175.83M |
| Date | Value |
|---|---|
| October 17, 2024 | 175.67M |
| October 16, 2024 | 177.10M |
| October 15, 2024 | 175.65M |
| October 14, 2024 | 175.65M |
| October 11, 2024 | 176.02M |
| October 10, 2024 | 175.29M |
| October 09, 2024 | 172.04M |
| October 08, 2024 | 173.84M |
| October 07, 2024 | 177.10M |
| October 04, 2024 | 177.10M |
| October 03, 2024 | 173.48M |
| October 02, 2024 | 174.21M |
| October 01, 2024 | 175.29M |
| September 30, 2024 | 176.02M |
| September 27, 2024 | 170.38M |
| September 26, 2024 | 167.84M |
| September 25, 2024 | 164.95M |
| September 24, 2024 | 164.95M |
| September 23, 2024 | 170.38M |
| September 20, 2024 | 171.82M |
| September 19, 2024 | 165.67M |
| September 18, 2024 | 160.97M |
| September 17, 2024 | 166.76M |
| September 16, 2024 | 163.86M |
| September 13, 2024 | 167.30M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.594M
Minimum
Dec 28 2022
235.09M
Maximum
Apr 01 2024
100.40M
Average
89.55M
Median
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 9.017M |
| Perspective Therapeutics Inc | -63.40M |
| Protalix BioTherapeutics Inc | 94.82M |
| Electromed Inc | 223.55M |
| Xtant Medical Holdings Inc | 85.83M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.481M |
| Total Expenses (Quarterly) | 9.756M |
| EPS Diluted (Quarterly) | -0.15 |
| Earnings Yield | -78.10% |
| Normalized Earnings Yield | -2006.72 |